We use cookies for a better user experience. Read our Privacy Policy

I Agree

Interventional Cardiology Devices Market

Interventional Cardiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Global Interventional Cardiology Devices Market: Snapshot

The primary driver of the demand for interventional cardiology devices is the increasing prevalence of coronary artery diseases. Organizations such as the WHO and CDC are consistently calling out the rampant growth in the number of patients suffering from heart problems and coronary artery complications. It has been predicted by the WHO that coronary artery disease will be responsible for almost 23.3 mn deaths by 2030. The causes of this growth in projected patients range from the increasing geriatric population to the obesity epidemic that has especially gripped the developed economies of the world. Both causes are at very high priority in terms of being causes for heart complications and relevant steps need to be taken to treat the increasing number of patients.

From the technological perspective, a lot of focus has been given to the development of existing interventional cardiology devices and the innovation of new ones. For instance, the advancements in diagnostic tools and monitoring tools have drastically improved the success rate of coronary artery disease treatment. Another parallel aspect driving the demand for interventional cardiology devices is the increasing demand for minimally invasive surgeries. Such procedures can dramatically reduce pain of surgery and healing period for heart problem treatments. Therefore, the inculcation of minimally invasive interventional cardiology devices into the healthcare industry on larger scales will certainly promote their use.

The global market for interventional cardiology devices is, however, currently subject to an intense level of competition. Market players are locked in a battle to increase sales volumes and are resorting to price cuts in order to achieve this. This practice is followed largely by regional players and globally prominent companies have to follow suit to hold the majority in global market values. This severely reduces the funds available for further research and development of interventional cardiology devices.

The global market for interventional cardiology devices is expected to be valued at US$9.36 bn by the end of 2016 and US$11.16 bn by the end of 2022. It is projected at a CAGR of 2.9% from 2014 to 2022.

North America to Dominate Interventional Cardiology Devices Demand

North America is expected to continue leading the consumption of interventional cardiology devices. By the end of 2022, North America is expected to generate a revenue of US$4.04 bn through its demand for interventional cardiology devices. This dominant share in the market is attributed to an advanced healthcare infrastructure that largely provides premium medical devices and is more open to incorporating innovative devices. This allows interventional cardiology device manufacturers to maintain profits while achieving a higher rate of research and development, thereby creating a constant cycle of improvements. The North America market for interventional cardiology devices is, however, expected to saturate over the coming years owing to a slower growth in the demand for relevant surgical procedures.

On the other hand, the growth of demand for interventional cardiology devices in Asia Pacific has just begun. This region houses a rapidly developing healthcare infrastructure. Coupled with the rising rate of medical tourism and the introduction of minimally invasive interventional cardiology devices, Asia Pacific is projected to show a CAGR of 4.8% from 2014 to 2022 in this market.

Drug-eluting Stents to Remain Leading Type of interventional cardiology device Used

Stents have consistently taken up the majority share in interventional cardiology device types. By the end of 2022, a projected US$6.89 bn will be generated through the sale of stents. Bare-metal, drug-eluting, and bio-absorbable stents are now commonly found. However, drug-eluting stents currently hold the greater demand, primarily due to their higher efficiency of treatment and the significantly reduced chances of the patient needing in-stent restenosis. The overall advantages of using drug-eluting stents are far greater than their predecessors, the bare-metal stents. At the same time, bio-absorbable stents have not caught on yet, although they are showing a steep increase in demand. This currently puts drug-eluting stents and their manufacturers at an advantage till 2022.

The top providers of interventional cardiology devices in the world include Boston Scientific, Abbott Vascular, Medtronic, St Jude Medical, and Volcano Corporation.

Interventional Cardiology Devices Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
       1.3.1 Secondary Research
       1.3.2 Primary Research
1.4 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Interventional Cardiology (IC) Devices Market (2013 & 2022)
2.2 Global Interventional Cardiology Devices Market Revenue, by Types, 2013 (USD Million)
2.3 Comparative Analysis: Global Interventional Cardiology Devices Market Revenue, by Geography, 2013 & 2022 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
       3.2.1 Increasing prevalence of coronary artery disease
       3.2.2 Rise in global obesity rate along with aging population likely to trigger the number of PCIs
                3.2.2.1 The absolute number of coronary heart disease deaths by decade of age, 2010-2040
       3.2.3 Penetration of new imaging technology greatly enhances PCI guidance and diagnosis rate
       3.2.4 Rising demand for minimally invasive surgeries
3.3 Market Restraints
       3.3.1 Decrease in average selling price
       3.3.2 Lack of efficient reimbursement system in emerging economies
       3.3.3 Slow growth in number of PCIs
3.4 Opportunities
       3.4.1 Advent of bio-absorbable stents projected as a viable alternative to drug eluting stents
       3.4.2 Emerging nations
3.5 Porter’s Five Force Analysis of the Global Interventional Cardiology Devices Market
       3.5.1 Bargaining power of suppliers
       3.5.2 Bargaining power of buyers
       3.5.3 Threat of substitutes
       3.5.4 Threat of new entrants
       3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Interventional Cardiology Devices Market, by Geography
3.7 Competitive Landscape
       3.7.1 Market Share Analysis: Global Interventional Cardiology Devices Market, 2014 (Value %)
3.8 Regulatory Framework
3.9 Value Chain Analysis
 
Chapter 4 Global Interventional Cardiology Devices Market, by Product Type
4.1 Introduction
       4.1.1 Global Interventional Cardiology Devices Market Revenue, by Type, 2012 – 2022 (USD Million)
4.2 Stents
       4.2.1 Global Stents Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.2.2 Bare Metal Stents
               4.2.2.1 Global Bare Metal Stents Market Revenue, 2012 – 2022(USD Million)
       4.2.3 Drug Eluting Stents (DES)
               4.2.3.1 Global Drug Eluting Stents Market Revenue, 2012 – 2022 (USD Million)
       4.2.4 Bio-absorbable Stents
               4.2.4.1 Global Bio-absorbable Stents Market Revenue, 2012 – 2022 (USD Million)
4.3 Catheters
       4.3.1 Global Interventional Cardiology Catheters Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.3.2 Angiography Catheters
               4.3.2.1 Global Angiography Catheters Market Revenue, 2012 – 2022 (USD Million)
       4.3.3 Intravascular Ultrasound (IVUS) Catheters
               4.3.3.1 Global Intravascular Ultrasound (IVUS) Catheters Market Revenue, 2012 – 2022 (USD Million)
       4.3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters
               4.3.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters Market Revenue, 2012 – 2022 (USD Million)
       4.3.5 Pulmonary Artery Catheters
               4.3.5.1 Global Pulmonary Artery Catheter Market Revenue, 2012 – 2022 (USD Million)
4.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
       4.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.4.2 Normal Balloons
               4.4.2.1 Global Normal Balloons Market Revenue, 2012 – 2022 (USD Million)
       4.4.3 Cutting Balloons
               4.4.3.1 Global Cutting Balloons Market Revenue, 2012 – 2022 (USD Million)
       4.4.4 Scoring Balloons
               4.4.4.1 Global Scoring Balloons Market Revenue, 2012 – 2022 (USD Million)
       4.4.5 Drug Eluting Balloons
               4.4.5.1 Global Drug Eluting Balloons Market Revenue, 2012 – 2022 (USD Million)
4.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires
       4.5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires Market Revenue, 2012 – 2022 (USD Million)
4.6 Other Accessories (introducer sheath systems, needles, forceps, etc.)
       4.6.1 Global Other Accessories (introducer sheath systems, needles, forceps, etc.) Market Revenue, 2012 – 2022 (USD Million)
4.7 Interventional Cardiology Systems
       4.7.1 Global Interventional Cardiology Systems Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.7.2 Intravascular Ultrasound (IVUS) Systems
               4.7.2.1 Global Intravascular Ultrasound (IVUS) Systems Market Revenue, 2012 – 2022 (USD Million)
       4.7.3 Fractional Flow Reserve (FFR) System
               4.7.3.1 Global Fractional Flow Reserve (FFR) Systems Market Revenue, 2012 – 2022 (USD Million)
       4.7.4 Optical Coherence Tomography (OCT) Systems
               4.7.4.1 Global Optical Coherence Tomography (OCT) Systems Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 5 Global Interventional Cardiology Devices Market, by Geography
5.1 Overview
       5.1.1 Global Interventional Cardiology Devices Market Revenue, by Geography, 2012 – 2022 (USD Million)
5.2 North America
       5.2.1 North America Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.3 Europe
       5.3.1 Europe Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.4 Asia-Pacific (APAC)
       5.4.1 Asia-Pacific Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.5 Latin America (LATAM)
       5.5.1 LATAM Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.6 MENA
       5.6.1 MENA Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.7 Rest of the World (RoW)
       5.7.1 RoW Interventional Cardiology Devices Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 6 Recommendations
6.1 Investing in Emerging Markets of Asia Pacific, Latin America, and Africa
6.2 Focus on improved and technologically advanced interventional cardiology devices
 
Chapter 7 Company Profiles
7.1 Abbott Laboratories, Inc.
       7.1.1 Company Overview
       7.1.2 Financial Overview
       7.1.3 Product Portfolio
       7.1.4 Business Strategies
       7.1.5 Recent Developments
7.2 B. Braun Melsungen AG
       7.2.1 Company Overview
       7.2.2 Financial Overview
       7.2.3 Product Portfolio
       7.2.4 Business Strategies
       7.2.5 Recent Developments
7.3 Boston Scientific Corporation
       7.3.1 Company Profile
       7.3.2 Financial Overview
       7.3.3 Product Portfolio
       7.3.4 Business Strategies
       7.3.5 Recent Developments
7.4 Cook Medical, Inc.
       7.4.1 Company Overview
       7.4.2 Financial Overview
       7.4.3 Product Portfolio
       7.4.4 Business Strategies
       7.4.5 Recent Developments
7.5 Johnson & Johnson (Cordis Corporation)
       7.5.1 Company Overview
       7.5.2 Financial Overview
       7.5.3 Product Portfolio
       7.5.4 Business Strategies
       7.5.5 Recent Developments
7.6 Medtronic, Inc.
       7.6.1 Company Overview
       7.6.2 Financial Overview
       7.6.3 Product Portfolio
       7.6.4 Business Strategies
       7.6.5 Recent Development
7.7 Smiths Medical
       7.7.1 Company Overview
       7.7.2 Financial Overview
       7.7.3 Product Portfolio
       7.7.4 Business Strategies
       7.7.5 Recent Developments
7.8 St. Jude Medical, Inc.
       7.8.1 Company Profile
       7.8.2 Financial Overview
       7.8.3 Product Portfolio
       7.8.4 Business Strategies
7.9 Terumo Corporation
       7.9.1 Company Overview
       7.9.2 Financial Overview
       7.9.3 Product Portfolio
       7.9.4 Business Strategies
       7.9.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Interventional Cardiology Devices Market (2013 & 2022)
TABLE 2 Global Interventional Cardiology Devices Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 3 Global Stents Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 4 Global Interventional Cardiology Catheters Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 5 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 6 Global Interventional Cardiology Systems Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 7 Global Interventional Cardiology Devices Market Revenue, by Geography, 2012 – 2022 (USD Million)
TABLE 8 North America Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 9 Europe Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 10 Asia-Pacific Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 11 LATAM Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 12 MENA Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)

List of Figures

 

FIG. 1 Interventional Cardiology Devices: Market Segmentation

FIG. 2 Global Interventional Cardiology Devices Market, by Types, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Interventional Cardiology Devices Revenue, by Geography, 2013 & 2022 (Value %)

FIG. 4 The absolute number of coronary heart disease deaths by decade of age, 2010-2040

FIG. 5 Porter’s Five Forces Analysis: Global Interventional Cardiology Devices Market

FIG. 6 Market Attractiveness Analysis: Global Interventional Cardiology Devices Market, by Geography (2013)

FIG. 7 Market Share Analysis, by Key Players: Global Interventional Cardiology Devices Market, 2014 (Value %)

FIG. 8 Value Chain Analysis: Global Interventional Cardiology Devices Market

FIG. 9 Global Bare Metal Stents Market Revenue, 2012 – 2022 (USD Million)

FIG. 10 Global Drug Eluting Stents Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Global Bio-absorbable Stents Market Revenue, 2012 – 2022 (USD Million)

FIG. 12 Global Angiography Catheters Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Intravascular Ultrasound (IVUS) Catheters Market Revenue, 2012 – 2022 (USD Million)

FIG. 14 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters Market Revenue, 2012 – 2022 (USD Million)

FIG. 15 Global Pulmonary Artery Catheter Market Revenue, 2012 – 2022 (USD Million)

FIG. 16 Global Normal Balloons Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 Global Cutting Balloons Market Revenue, 2012 – 2022 (USD Million)

FIG. 18 Global Scoring Balloons Market Revenue, 2012 – 2022 (USD Million)

FIG. 19 Global Drug Eluting Balloons Market Revenue, 2012 – 2022 (USD Million)

FIG. 20 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Global Other Accessories (Introducer sheath systems, needles, forceps, etc.) Market Revenue, 2012 – 2022 (USD Million)

FIG. 22 Global Intravascular Ultrasound (IVUS) Systems Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 Global Fractional Flow Reserve (FFR) Systems Market Revenue, 2012 – 2022 (USD Million)

FIG. 24 Global Optical Coherence Tomography (OCT) Systems Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 RoW Interventional Cardiology Devices Market Revenue, 2012 – 2022 (USD Million)

FIG. 26 Abbott Laboratories, Inc.: Annual Revenue, 2012 – 2014 (USD Million)

FIG. 27 B. Braun Melsungen AG: Annual Revenue, 2012 – 2014 (USD Million)

FIG. 28 Boston Scientific Corporation: Annual Revenue, 2012 – 2014 (USD million)

FIG. 29 Johnson & Johnson: Annual Revenue, 2012 – 2014 (USD Million)

FIG. 30 Medtronic, Inc., Annual Revenue: 2012 - 2014 (USD Million)

FIG. 31 Smiths Medical: Annual Revenue, 2012 – 2014 (USD Million)

FIG. 32 St. Jude Medical, Inc.: Annual Revenue, 2012 – 2014 (USD Million)

FIG. 33 Terumo Corporation: Annual Revenue, 2012 – 2014 (USD Million)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

548

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved